# The Utility of Cell-free DNA Methylation Markers for Hepatocellular Carcinoma

> **NCT05573217** · — · UNKNOWN · sponsor: **National Taiwan University Hospital** · enrollment: 180 (estimated)

## Conditions studied

- Cell-free Methylation Markers

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05573217
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-07-01
- **Primary completion:** 2023-06-30
- **Final completion:** 2023-06-30
- **Target enrollment:** 180 (ESTIMATED)
- **Last updated:** 2022-10-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05573217

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05573217, "The Utility of Cell-free DNA Methylation Markers for Hepatocellular Carcinoma". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT05573217. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*